Anti egfr rabbit polyclonal antibody clone 1005

Manufactured by Santa Cruz Biotechnology

Sourced in United States

The Anti-EGFR rabbit polyclonal antibody (clone 1005) is a laboratory research tool used to detect the epidermal growth factor receptor (EGFR) protein in various experimental applications. This antibody is produced in rabbits and recognizes the EGFR protein.

Automatically generated - may contain errors

Lab products found in correlation

Ready to use anti er rabbit monoclonal antibody clone sp1, by Agilent Technologies (2 mentions) Herceptest, by Agilent Technologies (2 mentions) Anti fscn1 mouse monoclonal antibody clone 55 k 2, by Santa Cruz Biotechnology (1 mentions) Envision system, by Agilent Technologies (1 mentions) Anti resistin mouse monoclonal antibody clone c 10, by Santa Cruz Biotechnology (1 mentions) Ready to use anti pr mouse monoclonal antibody clone pgr636, by Agilent Technologies (1 mentions) Ready to use anti ki 67 mouse monoclonal antibody clone mib 1, by Agilent Technologies (1 mentions)

Close spelling variants of this product

Polyclonal rabbit anti-EGFR (1005; EGFR 1005 antibody Anti-EGFR (1005) EGFR (1005) Rabbit anti-EGFR antibody Rabbit anti-EGFR Anti-EGFR antibody Polyclonal rabbit antibody EGFR antibody Anti-EGFR

2 protocols using anti egfr rabbit polyclonal antibody clone 1005

Immunohistochemical Staining of Tissue

Cited 1 time

Check if the same lab product or an alternative is used in the 5 most similar protocols

IHC staining of paraffin-embedded tissue sections was carried out using the Envision System (Dako, Glostrup, Denmark) as described previously^{13 (link)}. The primary antibodies used were as follows: anti-FSCN1 mouse monoclonal antibody (clone 55k-2, diluted at 1:100, Santa Cruz Biotechnology, Santa Cruz, USA); anti-EGFR rabbit polyclonal antibody (clone 1005, diluted at 1:100, Santa Cruz Biotechnology); HercepTest (Dako); ready-to-use anti-ER rabbit monoclonal antibody (clone SP1, Dako); ready-to-use anti-PR mouse monoclonal antibody (clone PR636, Dako).

Wang C.Q., Li Y., Huang B.F., Zhao Y.M., Yuan H., Guo D., Su C.M., Hu G.N., Wang Q., Long T., Wang Y., Tang C.H, & Li X. (2017). EGFR conjunct FSCN1 as a Novel Therapeutic Strategy in Triple-Negative Breast Cancer. Scientific Reports, 7, 15654.

+ Open protocol

+ Expand

Immunohistochemical Analysis of Breast Cancer Biomarkers

Cited 1 time

Check if the same lab product or an alternative is used in the 5 most similar protocols

We followed the methods of Wang et al. [18 (link)]. The primary antibodies consisted of anti-resistin mouse monoclonal antibody (clone C-10, diluted at 1 : 25; Santa Cruz Biotechnology, Santa Cruz, USA), anti-EGFR rabbit polyclonal antibody (clone 1005, diluted at 1 : 100; Santa Cruz Biotechnology), anti-ERK1/2 rabbit monoclonal antibody (clone EPR18444, diluted at 1 : 1000; Abcam, Cambridge, England), ready-to-use anti-ER rabbit monoclonal antibody (clone SP1, Dako), ready-to-use anti-PR mouse monoclonal antibody (clone PgR636, Dako), HercepTest (Dako), and ready-to-use anti-Ki-67 mouse monoclonal antibody (clone MIB-1, Dako).

Zeng Y., Tang C.H., Wang Y., Lu H.J., Huang B.F., Wang Q., Shao J.K., Jin L.L., Wang C.Q, & Teng L.S. (2020). Combined High Resistin and EGFR Expression Predicts a Poor Prognosis in Breast Cancer. BioMed Research International, 2020, 8835398.

+ Open protocol

+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Revolutionizing how scientists
search and build protocols!